Search Results
Dec 02, 2025, 09:00 ET InSkill Receives Frost and Sullivan's 2025 Global New Product Innovation Recognition for Its Industrial AI Copilot Platform
https://inskill.ai/l/frost-sullivan-industrial-ai-copilot-platform-award/ContactE: [email protected]
More news about: Frost & Sullivan
Dec 02, 2025, 09:00 ET InSkill Receives Frost and Sullivan's 2025 Global New Product Innovation Recognition for Its Industrial AI Copilot Platform
https://inskill.ai/l/frost-sullivan-industrial-ai-copilot-platform-award/ContactE: [email protected]
More news about: Frost & Sullivan
Dec 02, 2025, 09:00 ET Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities
paxalisib, a brain-penetrant dual PI3K/mTOR inhibitor currently in clinical trials for both brain cancer and advanced breast cancer, advancing the PD-L1 degrader program, and for general corporate purposes. The Company expects the net proceeds from the PIPE, combined with the existing cash and cash equivalents,
More news about: Kazia Therapeutics Limited
Dec 02, 2025, 08:57 ET Tiger Group Offers Assets from Turf Company's Georgia Plant
Texas Bragg and Load TrailUtility and cargo trailers by Arising, Homesteader, American Hauler and others(2) Kubota Tractors, L3302HST & L3301DForklifts by Linde, Clark and Komatsu ranging in capacity from 5,500 to 8,000 pound, some from as late as 2022OTHER
More news about: Tiger Group
Dec 02, 2025, 08:34 ET Li-ion Battery Cathode and Anode Ten-Year Material Outlook, by IDTechEx
(mid-silicon) or at >50 wt% (high-silicon/silicon dominant) to enter the market."Silicon anodes can enable Li-ion energy densities above 1000 Wh/l and 400 Wh/kg, while rate capability and charging times can also be improved. However, achieving long-term cycle stability has been a significant challenge
More news about: IDTechEx
Dec 02, 2025, 08:15 ET Christopher Gandy Elected President of National Association of Insurance and Financial Advisors (NAIFA) for the 2026-2027 Term
develop the foundation of who I am—not only as an athlete or a lifelong learner, but as a leader," said Gandy.About Christopher L. GandyChristopher L. Gandy is the Founder and CEO of
More news about: Christopher Gandy
Dec 02, 2025, 08:15 ET AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers
Long-term immune reconstitution and final 1-year follow-up after fixed-duration venetoclax-obinutuzumab (VenO) in first-line (1L) chronic lymphocytic leukemia (CLL): Results from the Phase III CRISTALLO trial
More news about: AbbVie Inc.
Dec 02, 2025, 08:02 ET TalentLMS Annual L&D Benchmark Report Reveals Training Is Key to Retention, Yet Heavy Workloads Block Learning Efforts
wide range of topics:L&D ownershipHow budgets have evolvedHow companies measure ROI and employee satisfactionBarriers to learningSkills gapsHow AI is reshaping learningL&D's impact on career growth and mobilityThree
More news about: TalentLMS
Dec 02, 2025, 08:00 ET JobKred Joins Visier's Skills OSI to Bridge APAC Skills Gaps and Align Talent Development with Tangible Business Outcomes
measurable business outcomes. The solution enables the proactive reduction of skills gaps and ensures every talent decision is data-driven, maximizing L&D ROI and boosting employee retention."The shift to a skills-based organization is a critical competitive advantage in today's dynamic market,
More news about: Visier
Dec 02, 2025, 07:07 ET AnChain.AI Announces Strategic Investment Round to Build Artificial Super Intelligence for Fighting Fraud
veteran fintech investor with deep experience across crypto and quantitative finance.Amino Capit a l – Palo Alto–based VC firm with $1B AUM focused on AI, and fintech. Existing investors also participated.Investor CommentaryCris
More news about: AnChain.AI
Dec 02, 2025, 07:00 ET Fräsch Announces Carlos Delgado as Vice President, Sales & General Manager
materials, architectural products, and manufacturing sectors. His career includes guiding the growth of architectural product divisions, managing P&L responsibility, and delivering sustained double-digit sales and profit growth in senior leadership positions.For more information about Frasch's
More news about: Fräsch
Dec 02, 2025, 07:00 ET Main Street Announces Follow-On Investment
revenues between $10 million and $150 million.Contacts:Main Street Capital CorporationDwayne L. Hyzak, CEO, [email protected]
More news about: Main Street Capital Corporation
Dec 02, 2025, 06:59 ET Satellite Ground Station Market worth $82.72 billion by 2030 - Exclusive Report by MarketsandMarkets™
(US), Kongsberg (Norway), Airbus (Netherlands), Lockheed Martin Corporation (US), Elbit System Limited (Israel), Boeing (US), Aselsan A.S. (Turkey), L3Harris Technologies, Inc. (US), Northrop Grumman (US), GMV Innovating Solutions S.L. (Spain), Kratos Defense & Security Solutions (US), Mitsubishi
More news about: MarketsandMarkets
Dec 02, 2025, 06:59 ET Garmin G5000H selected for Brazilian Air Force UH-60 Black Hawk helicopters
G5000H® integrated flight deck has been selected by the Brazilian Air Force, through Ace Aeronautics, to modernize the cockpits of 24 UH-60L Black Hawk helicopters. The G5000H cockpit is IFR certified and delivers the capabilities military operators need through its modular open systems architecture
More news about: Garmin International, Inc.
Dec 02, 2025, 06:00 ET Acannability™ Calls for Industry-Wide Consumer and Lawmaker Education: Most of the Cannabis Plant is Non-Intoxicating
CHICAGO, Dec. 2, 2025 /PRNewswire/ -- A long-standing misconception needs correction: Cannabis Sativa L is not a single, uniform substance, but a chemically diverse plant made up of hundreds of distinct cannabinoids. The majority of these compounds are non-intoxicating.
More news about: Acannability
Dec 02, 2025, 04:15 ET LONGi pubblica i dati globali della tecnologia BC testata sul campo: performance e affidabilità superiori a ogni aspettativa
di LONGi fanno registrare una crescita stabile nella generazione di energia watt per watt in tutto il mondo, con margini di guadagno compresi tra l'1,21% e il 3,92%, oltre a performance particolarmente eccezionali in determinati scenari.Rendimenti robusti nei climi europei Una valutazione
More news about: LONGi Solar
Dec 02, 2025, 04:12 ET Yatsen Group、「Beauty Innovation Insight」白書を発表
2024年時点*5 2021年第三者検査機関によるパーフェクトダイアリーの「スリムヒールリップスティック」（カラー：L02、L04）に対して、製品カーボンフットプリント評価を実施。
More news about: Yatsen Holding Limited
Dec 02, 2025, 04:00 ET Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy
Hospital, the lead trial center. The study is designed to evaluate two combination regimens in patients with CLDN18.2-positive, HER2-negative, and PD-L1-positive (CPS≥1) unresectable or metastatic gastric cancer or gastroesophageal junction adenocarcinoma (GC/GEJC): ATG-022 in combination with
More news about: Antengene Corporation Limited
Dec 02, 2025, 04:00 ET PepsiCo anuncia parceria global com a equipe Mercedes-AMG Petronas de Formula 1® para 2026
Commission", publicado pela Federação Internacional de Automobilismo²AMERICAN COLLEGE OF SPORTS MEDICINE. THOMAS, D. T.; ERDMAN, K. A.; BURKE, L. M. American College of Sports Medicine joint position statement: Nutrition and athletic performance. Medicine & Science in Sports & Exercise,
More news about: PepsiCo
Dec 02, 2025, 03:23 ET À l'occasion du 19e Congrès européen sur les céphalées, AbbVie va présenter les données de la phase 3 d'ECLIPSE démontrant la supériorité de l'atogépant (AQUIPTA®) par rapport au placebo dans le soulagement complet de la douleur pour le traitement aigu de la migraine
Tolerability of Atogepant for the Acute Treatment of Migraine: Results from the ECLIPSE Trial. European Headache Congress 2025.2 Dong L, Dong W, Jin Y, et al. The Global Burden of Migraine : A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region. Pain and Therapy.
More news about: AbbVie
Dec 01, 2025, 23:59 ET AbbVie präsentiert auf dem 19. European Headache Congress Phase-3-Daten aus der ECLIPSE-Studie, die die Überlegenheit von Atogepant (AQUIPTA®) gegenüber Placebo bei der Schmerzlinderung in der Akutbehandlung von Migräne belegen
Tolerability of Atogepant for the Acute Treatment of Migraine: Results from the ECLIPSE Trial. European Headache Congress 2025.2 Dong L, Dong W, Jin Y, et al. The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region. Pain and Therapy.
More news about: AbbVie
Dec 01, 2025, 15:45 ET J-L CAUVIN MAKES THE NJ-11 BALLOT WITH TRUE GRASSROOTS EFFORT
/PRNewswire/ -- J-L Cauvin's campaign for Congress achieved a major milestone this week, officially securing a spot on the ballot in New Jersey's 11th Congressional District. Without the benefit of a pre-existing campaign apparatus, party-machine backing, or high-profile national endorsements, J-L and a team
More news about: JL for NJ 2026
Dec 01, 2025, 14:25 ET LIFE TIME SIGNS LEASE AT 175 THIRD STREET, THE NEWEST DEVELOPMENT IN CHARNEY COMPANIES AND TAVROS' GOWANUS WHARF
lives through its more than 185 athletic country clubs across the U.S. and Canada, the complimentary and comprehensive Life Time app featuring its L•AI•C™ AI-powered health companion, and more than 30 iconic athletic events. Serving people ages 90 days to 90+ years, the Life Time ecosystem uniquely delivers
More news about: Life Time, Inc.
Dec 01, 2025, 12:16 ET AbbVie presentará datos de fase 3 de ECLIPSE en el 19º Congreso Europeo de Cefaleas
Tolerability of Atogepant for the Acute Treatment of Migraine: Results from the ECLIPSE Trial. European Headache Congress 2025.2 Dong L, Dong W, Jin Y, et al. The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region. Pain and Therapy.
More news about: AbbVie
Dec 01, 2025, 12:00 ET Invesco Closed-End Funds Declare Dividends
are bought on the secondary market and may trade at a discount or premium to NAV. Regular brokerage commissions apply.NOT A DEPOSIT l NOT FDIC INSURED l NOT GUARANTEED BY THE BANK | MAY LOSE VALUE | NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCYCONTACT: Closed-End Funds 800-341-2929
More news about: Invesco Ltd.